Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy

M Hashemi, MS Moosavi, HM Abed, M Dehghani… - Pharmacological …, 2022 - Elsevier
Initiation and development of cancer depend on multiple factors that mutations in genes and
epigenetic level can be considered as important drivers. Epigenetic factors include a large …

Beyond controlling cell size: functional analyses of S6K in tumorigenesis

X Wu, W Xie, W Xie, W Wei, J Guo - Cell Death & Disease, 2022 - nature.com
As a substrate and major effector of the mammalian target of rapamycin complex 1
(mTORC1), the biological functions of ribosomal protein S6 kinase (S6K) have been …

Benefit delayed immunosenescence by regulating CD4+T cells: A promising therapeutic target for aging‐related diseases

T Xia, Y Zhou, J An, Z Cui, X Zhong, T Cui, B Lv… - Aging …, 2024 - Wiley Online Library
CD4+ T cells play a notable role in immune protection at different stages of life. During
aging, the interaction between the body's internal and external environment and CD4+ T …

Tumour microenvironment and aberrant signaling pathways in cisplatin resistance and strategies to overcome in oral cancer

S Biswal, M Panda, RK Sahoo, SK Tripathi… - Archives of Oral …, 2023 - Elsevier
Objective Oral cancer is the sixteenth most prevalent cancer in the world and the third-most
in India. Despite of several treatment modalities, the cure rate of oral cancer is still low due to …

Targeting cancer stem cells as a strategy for reducing chemotherapy resistance in head and neck cancers

D Dorna, J Paluszczak - Journal of Cancer Research and Clinical …, 2023 - Springer
Purpose Resistance to chemotherapy and radiotherapy is the primary cause of a poor
prognosis in oncological patients. Researchers identified many possible mechanisms …

RNA N6-methyladenosine (m6A) modification in HNSCC: molecular mechanism and therapeutic potential

X Sun, S Fu, X Yuan, X Pu, RK Wang, X Wang… - Cancer Gene …, 2023 - nature.com
Head and neck squamous cell carcinoma ranks seventh in incidence of malignant tumours
in the world. Although there are treatments including surgery, radiotherapy and …

[HTML][HTML] Mechanisms governing lineage plasticity and metabolic reprogramming in cancer

LM Perez, SV Venugopal, A St Martin, SJ Freedland… - Trends in Cancer, 2024 - cell.com
Dynamic alterations in cellular phenotypes during cancer progression are attributed to a
phenomenon known as 'lineage plasticity'. This process is associated with therapeutic …

Transcription factor LHX9 (LIM Homeobox 9) enhances pyruvate kinase PKM2 activity to induce glycolytic metabolic reprogramming in cancer stem cells, promoting …

H Zhao, R Jiang, Z Feng, X Wang, C Zhang - Journal of Translational …, 2023 - Springer
Background Glycolytic metabolic reprogramming is a phenomenon in which cells undergo
altered metabolic patterns during malignant transformation, mainly involving various aspects …

Roles of mitochondria in oral squamous cell carcinoma therapy: Friend or foe?

J Bai, L Wu, X Wang, Y Wang, Z Shang, E Jiang… - Cancers, 2022 - mdpi.com
Simple Summary Although many therapies have been applied in oral squamous cell
carcinoma, these therapies are still unsatisfactory. Recently, the mitochondrial role in oral …

The circRNA hsa-circ-0013561 regulates head and neck squamous cell carcinoma development via the miR-7-5p/PDK3 axis

K Tian, L Zheng, T Yuan, X Chen, Q Chen, X Xue… - Cancer Cell …, 2024 - Springer
Abstract Background Circular RNAs (circRNAs) belong to a class of covalently closed single
stranded RNAs that have been implicated in cancer progression. Former investigations …